Isabl

Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enables compliant communication with patients. In doing so, we help patients access diagnoses, clinical trials, and treatments as early as possible.

shared extracted concept terms: patient; shared product terms: develop, analyze, patient, genetic; shared product theme: health and clinical care; same category: AI infrastructure; shared affiliation: Y Combinator

Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes. Our vision is a world in which all patients have effective, personalized treatment, because therapies

shared extracted concept terms: patient; shared product terms: patient, biology, up, develop; shared product theme: health and clinical care; shared affiliation: Y Combinator

We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.

shared product terms: cancer, test, few, run; shared product theme: health and clinical care; shared affiliation: Y Combinator

Auricle is a medical device company building a breakthrough neurostimulation implant to restore hearing in millions of patients who no longer benefit from hearing aids, get less than 60% on a word recognition test, but aren't prepared to make the jump to a cochlear implant. Our approach preserves remaining natural hearing through a reversible and less invasive surgery, addressing the key concerns that hold most patients back from getting a cochlear implant (currently the only treatment option fo

shared extracted concept terms: patient; shared product terms: breakthrough, patient, test, treatment; shared product theme: health and clinical care; same category: AI infrastructure; shared affiliation: Y Combinator

NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.

shared extracted concept terms: cancer, patient; shared product terms: cancer, patient, treatment; shared product theme: health and clinical care; shared affiliation: Y Combinator

Miphic enables the switch from long and expensive drug development to mitochondrial precision medicine that saves the lives of blood cancer patients.

shared extracted concept terms: cancer, patient; shared product terms: cancer, patient, precision; shared product theme: health and clinical care